Work

All-oral ixazomib, cyclophosphamide, and dexamethasone for transplant-ineligible patients with newly diagnosed multiple myeloma

Year: 2018

Type: article

Source: European Journal of Cancer

DOI: 10.1016/j.ejca.2018.09.011

Authors: Meletios A. Dimopoulos, Sebastian Grosicki, Wiesław W. Jędrzejczak, Hareth Nahi, Astrid Gruber, Markus Hansson, Neeraj Gupta, Catriona Byrne, Richard Labotka, Zhaoyang Teng, Huyuan Yang, Norbert Grzasko, Shaji Kumar

Institutions: National and Kapodistrian University of Athens, Medical University of Silesia, Medical University of Warsaw, Karolinska University Hospital, Lund University, Skåne University Hospital, Takeda Oncology (United States), Medical University of Lublin, Lublin Oncology Center, Mayo Clinic

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Takeda Oncology

OpenAlex ID: W2901427490

FWCI: 2.279

Cites: 28

Cited by: 33

Related to: 10